Care Redesign

Has the Time Come for a Unique Patient Identifier for the U.S.?

Article · February 21, 2018

Two decades ago, the Health Insurance Portability and Accountability Act (HIPAA) required the adoption of a unique health identifier for every individual, employer, health plan, and health care provider. This mandate was subsequently overruled by Congress because of patient privacy concerns. Since then, the U.S. has made the largest capital investment in catalyzing the adoption of electronic health records (EHRs) in history.

Yet that $30+ billion capital investment has not delivered on its promise of higher-quality, more cost-efficient care. Why? One important reason is the lack of a unique patient identifier system and the fact that without one, it’s very difficult to link disparate data to obtain a comprehensive picture of any one patient’s health care experiences. It’s time to revisit Congress’s fears about unique patient identifiers and institute a system that will enable more complete and accurate patient records.

Developing a unique patient identifier system would have many benefits. When accurate information is attached to the right patient, data access is timelier for clinical, administrative, quality improvement, and research purposes; inappropriate care, redundant tests, and medical errors are reduced; and health information exchange becomes easier — within organizations as well as between. Identifiers are also beneficial for patient mobility, allowing information to be linked to patients and following them as they move. And when patients have access to their complete records, they’re better able to advocate for themselves and manage their clinical conditions.

The current U.S. system for identifying patients relies on demographic data such as name and birth date, which sometimes are not unique to individuals. Because of this, it’s possible to link only 90–95% of records uniquely between disparate data sets. The result is high rates of duplicate or split records, posing potential risks to patient safety. For example, information about abnormal test results or medication allergies may reside in records that are not linked to the correct patient and the absence of a comprehensive patient record may result in redundant testing. Sorting out the remaining 5–10% of unmatched records is labor intensive and costly, yet it is often essential, especially in clinical care.

Even though unique patient identifiers have considerable support from the health information technology industry and many providers, they are very controversial in the United States. A highly vocal minority fears patient data will be exploited by governments and/or industry and that privacy might be even harder to protect than it is today. Congress responded to those concerns in 1998 when it prohibited the use of federal funds to investigate or create unique patient identifiers.

Looking to Other Countries

Unique patient identifiers have now been implemented in a number of places, including Ireland, the Nordic countries, and the United Kingdom. Scotland’s Community Health Index (CHI) number and England’s National Health Service (NHS) number allow disparate data sources to be reliably connected to minimize misidentification and catalyze research with linked anonymized data sets.

The NHS number, which does not itself carry any information about a person, allows clinicians to accurately convey information about patients to other health care providers, and simplifies many common tasks: sending discharge summaries to a patient’s primary care physician, making referrals to specialists, linking pathology and other reports to an individual’s records, and delivering prescriptions to pharmacists.

Starting with the States

Despite these advantages and the positive experiences in these countries, there is little appetite in the U.S. for pushing forward with identifiers at the federal level. At the state level, however, the outlook is more promising. Nevada and Minnesota have passed legislation legalizing the use of patient identifiers and can serve as testing grounds for clinical data exchange within their borders.

At the federal level, the U.S. Department of Health and Human Services and the Office of the National Coordinator for Health Information Technology should advocate that Congress lift the 1998 prohibition. The agencies should sponsor cost-benefit analyses and pilots to demonstrate the benefits and identify the challenges associated with introducing identifiers. Strict penalties would need to be established for privacy breaches, identity theft, and other types of abuse. If state-level implementations were successful, a national patient identifier could be reconsidered.

With billions of dollars having been spent on EHR implementation, the health care system must vigorously investigate more efficient ways to connect fragmented patient data, an effort that is increasingly relevant as the U.S. moves from a fee-for-service to a value-based health care system focusing on outcomes and populations.  If pursued, this change needs to be done with a public mandate, strict penalties for breaches of privacy, and an explicit strategy to improve access to comprehensive, longitudinal records to improve patient care, minimize duplicate records, and facilitate secondary uses of these data to support clinical audits, quality improvement, and research.

New call for submissions ­to NEJM Catalyst

Now inviting longform articles

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From Care Redesign
Cleveland Clinic Time-to-Treatment Cancer Programming Overall Scorecard 2015-2017 Sample

Reducing Time-to-Treatment for Newly Diagnosed Cancer Patients

How Cleveland Clinic initiated a multidisciplinary program to reduce time-to-treatment and accomplish a 33% reduction.

Treatment Authorization Increases and Rapid Boost in New Mexico Medicaid Members Treated for Chronic HCV

A Collaborative Model to Expand Medicaid Treatment Coverage for Chronic Hepatitis C Virus

How managing the benefit coverage expansion for the treatment of HCV in New Mexico was successfully achieved after less than 2 years.

Data Analytics Improves Clinical Care

Care Redesign Survey: How Data and Analytics Improve Clinical Care

Data and analytics are a key means for clinicians, clinical leaders, and executives to transform health care delivery. Yet health care organizations have work to do in getting measures right and much to learn about effective use of data, according to our most recent Insights Council survey.

Nobody Wants a Waiting Room sketch

Nobody Wants a Waiting Room

A study in system change.

Orszag02_pullquote - In Defense of the Hospital Readmissions Reduction Program HRRP

In Defense of the Federal Hospital Readmissions Reduction Program

In the current debate about HRRP, the evidence tilts toward no effect or a beneficial one on mortality, says the former Director of the U.S. Office of Management and Budget.

odel for Complex Gynecologic Care Team at the Women's Health Institute

An Innovative Approach to Treating Complex Gynecologic Conditions

How the Women’s Health Institute at The University of Texas at Austin designed their clinic to provide comprehensive, team-based, and patient-centered care for women.

Massachusetts Community Health Centers Collaborative Teledermatology Process

A Teledermatology Initiative to Increase Access for Community Health Center Patients

A group of seven community health centers in Massachusetts collaborated to implement a teledermatology program that improved access to specialty care for patients with skin conditions and reduced overall dermatology spending.

Chang05_pullquote interpersonal medicine

Beyond Evidence-Based Medicine

Interpersonal medicine is not just about being nice — it’s about being effective.

Summary of Comprehensive Approach to Physician Behavior and Practice Change

Engaging Stakeholders to Produce Sustainable Change in Surgical Practice

How an initiative designed to improve patient outcomes and satisfaction while containing costs led to sustainable change in surgical practice and physician behavior.

Myths and Realities of Opioid Use Disorder Treatment.

Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and Realities

There is a realistic, scalable solution for reaching the millions of Americans with opioid use disorder: mobilizing the primary care physician (PCP) workforce to offer office-based addiction treatment with buprenorphine, as other countries have done.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Coordinated Care

131 Articles

Reducing Time-to-Treatment for Newly Diagnosed Cancer…

How Cleveland Clinic initiated a multidisciplinary program to reduce time-to-treatment and accomplish a 33% reduction.

Care Integration

67 Articles

Integrated Care Lessons from Across the…

Just throwing things together doesn’t make for integrated care. If we spent more time looking…

Design Thinking

15 Articles

Nobody Wants a Waiting Room

A study in system change.

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now